HIV « Science and Enterprise

Start-Up Lands $10M for Gene-Editing HIV Treatments

By Alan, on September 6th, 2017%

A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round. . . . → Read More: Start-Up Lands $10M for Gene-Editing HIV Treatments

Gene Editing Could Lead to an HIV Cure

By Alan, on August 3rd, 2017%

Researchers at Temple University and the University of Pittsburgh published a study, which involved gene editing to remove HIV DNA from rat and mouse models. . . . → Read More: Gene Editing Could Lead to an HIV Cure

Messenger RNA Engineered to Produce Antibodies

By Alan, on March 3rd, 2017%

Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies. . . . → Read More: Messenger RNA Engineered to Produce Antibodies

Biotech, Univ of Miami Spin-Off Vaccine Company

By Alan, on October 28th, 2016%

Biotechnology company Heat Biologics Inc. is licensing research from University of Miami in Florida to develop vaccines against infectious diseases, starting with the Zika virus, in a new subsidiary. . . . → Read More: Biotech, Univ of Miami Spin-Off Vaccine Company

Refillable HIV Prevention Implant in Development

By Alan, on July 14th, 2016%

A device implanted under the skin providing 60 days of antiretroviral drugs to prevent HIV infection is in development at Houston Methodist Research Institute. . . . → Read More: Refillable HIV Prevention Implant in Development

Start-Up Licenses Genetics Technology for HIV Diagnostics

By Alan, on May 19th, 2016%

David Raiser, left, and Iain MacLeod, founders of Aldatu Biosciences (Aldatu Biosciences)

19 May 2016. A spin-off company from Harvard University is licensing genetics research to develop more powerful tools to detect drug-resistant strains of HIV. Financial details of the agreement between the 2 year-old Aldatu Biosciences Inc. and Harvard were not disclosed.

Gates Funding RNA Treatment for HIV Infection

By Alan, on January 12th, 2016%

RNA molecule illustration (Nicolle Rager Fuller, National Science Foundation)

12 January 2016. The Bill and Melinda Gates Foundation is backing a biotechnology company’s early development of antibodies to treat human immunodeficiency virus or HIV based on RNA, nucleic acids expressed by a person’s genetic code. The foundation is supporting the work of Moderna . . . → Read More: Gates Funding RNA Treatment for HIV Infection

USC, Biotech Edit Genes in Stem Cells for HIV Therapy

By Alan, on November 10th, 2015%

Paula Cannon (University of Southern California)

10 November 2015. A lab at University of Southern California and biotechnology company developed a technique for editing genomes in blood-forming stem cells as a potential treatment for HIV infection. The team from the lab of USC medical school professor Paula Cannon and Sangamo BioSciences in Richmond, . . . → Read More: USC, Biotech Edit Genes in Stem Cells for HIV Therapy

Research Group, CureVac Partner on AIDS Vaccine

By Alan, on September 10th, 2015%

(Rhoda Baer, National Cancer Institute)

10 September 2015. An organization encouraging development of AIDS vaccines and the pharmaceutical company CureVac are collaborating on creating a potent AIDS vaccine technology. Financial and intellectual property aspects of the partnership between the not-for-profit International AIDS Vaccine Initiative, or IAVI, and CureVac in Tubingen, Germany were not . . . → Read More: Research Group, CureVac Partner on AIDS Vaccine

Preventive Drugs Found to Stop New HIV Infections

By Alan, on September 2nd, 2015%

Scanning electron micrograph of HIV particles infecting a human T cell (NIH.gov)

2 September 2015. A large-scale study of preexposure prophylaxis or PrEP, the use of antiviral drugs to prevent HIV infection, found the practice prevented new HIV infections among Kaiser Permanente clients in San Francisco over a 32-month period. Results of the . . . → Read More: Preventive Drugs Found to Stop New HIV Infections

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise